WallStreetZenWallStreetZen

NASDAQ: NRIX
Nurix Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NRIX

Based on 7 analysts offering 12 month price targets for Nurix Therapeutics Inc

Min Forecast
$15.00+49.55%
Avg Forecast
$27.29+172.04%
Max Forecast
$33.00+229.01%

Should I buy or sell NRIX stock?

Based on 7 analysts offering ratings for Nurix Therapeutics Inc.

Strong Buy
Strong Buy
3 analysts 42.86%
Buy
3 analysts 42.86%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NRIX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NRIX as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their NRIX stock forecasts and price targets.

NRIX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-14
lockedlocked$00.00+00.00%2025-10-14
lockedlocked$00.00+00.00%2025-10-10
lockedlocked$00.00+00.00%2025-10-10
lockedlocked$00.00+00.00%2025-07-10
Stephens & Co.
Bottom 8%
8
Strong BuyReiterates$30.00+199.10%2025-07-10
Needham
Top 4%
97
BuyReiterates$27.00+169.19%2025-04-29

1 of 1

Forecast return on equity

Is NRIX forecast to generate an efficient return?

Company
-57.56%
Industry
93.13%
Market
-61.61%
NRIX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NRIX forecast to generate an efficient return on assets?

Company
-41.01%
Industry
35.76%
NRIX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NRIX earnings per share forecast

What is NRIX's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$3.15
Avg 2 year Forecast
-$3.48
Avg 3 year Forecast
-$3.23

NRIX revenue forecast

What is NRIX's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$81.1M-3.11%
Avg 2 year Forecast
$82.0M-2.05%
Avg 3 year Forecast
$104.5M+24.91%
NRIX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NRIX revenue growth forecast

How is NRIX forecast to perform vs Biotechnology companies and vs the US market?

Company
5.73%
Industry
89.75%
Market
11.9%
NRIX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NRIX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NRIX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NRIX$10.03$27.29+172.04%Strong Buy
AVXL$9.01$44.00+388.35%Strong Buy
AKBA$2.92$7.50+156.85%Buy
DAWN$7.47$20.50+174.43%Buy
URGN$16.93$28.14+66.23%Strong Buy
View Top Biotech Stocks

Nurix Therapeutics Stock Forecast FAQ

Is Nurix Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: NRIX) stock is to Strong Buy NRIX stock.

Out of 7 analysts, 3 (42.86%) are recommending NRIX as a Strong Buy, 3 (42.86%) are recommending NRIX as a Buy, 1 (14.29%) are recommending NRIX as a Hold, 0 (0%) are recommending NRIX as a Sell, and 0 (0%) are recommending NRIX as a Strong Sell.

If you're new to stock investing, here's how to buy Nurix Therapeutics stock.

What is NRIX's earnings growth forecast for 2025-2027?

(NASDAQ: NRIX) Nurix Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 4.11%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16%.

Nurix Therapeutics's earnings in 2025 is -$244,785,000.On average, 7 Wall Street analysts forecast NRIX's earnings for 2025 to be -$242,290,460, with the lowest NRIX earnings forecast at -$256,021,842, and the highest NRIX earnings forecast at -$224,499,633. On average, 9 Wall Street analysts forecast NRIX's earnings for 2026 to be -$267,638,929, with the lowest NRIX earnings forecast at -$342,900,125, and the highest NRIX earnings forecast at -$163,761,719.

In 2027, NRIX is forecast to generate -$248,487,265 in earnings, with the lowest earnings forecast at -$319,066,259 and the highest earnings forecast at -$189,133,253.

What is NRIX's revenue growth forecast for 2025-2027?

(NASDAQ: NRIX) Nurix Therapeutics's forecast annual revenue growth rate of 5.73% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 89.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.9%.

Nurix Therapeutics's revenue in 2025 is $83,687,000.On average, 7 Wall Street analysts forecast NRIX's revenue for 2025 to be $6,233,785,874, with the lowest NRIX revenue forecast at $4,610,776,540, and the highest NRIX revenue forecast at $7,457,693,292. On average, 7 Wall Street analysts forecast NRIX's revenue for 2026 to be $6,302,365,899, with the lowest NRIX revenue forecast at $3,874,925,174, and the highest NRIX revenue forecast at $16,309,283,279.

In 2027, NRIX is forecast to generate $8,037,163,749 in revenue, with the lowest revenue forecast at $4,997,423,340 and the highest revenue forecast at $16,320,815,794.

What is NRIX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: NRIX) forecast ROA is -41.01%, which is lower than the forecast US Biotechnology industry average of 35.76%.

What is NRIX's Price Target?

According to 7 Wall Street analysts that have issued a 1 year NRIX price target, the average NRIX price target is $27.29, with the highest NRIX stock price forecast at $33.00 and the lowest NRIX stock price forecast at $15.00.

On average, Wall Street analysts predict that Nurix Therapeutics's share price could reach $27.29 by Oct 14, 2026. The average Nurix Therapeutics stock price prediction forecasts a potential upside of 172.04% from the current NRIX share price of $10.03.

What is NRIX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: NRIX) Nurix Therapeutics's current Earnings Per Share (EPS) is -$2.97. On average, analysts forecast that NRIX's EPS will be -$3.15 for 2025, with the lowest EPS forecast at -$3.33, and the highest EPS forecast at -$2.92. On average, analysts forecast that NRIX's EPS will be -$3.48 for 2026, with the lowest EPS forecast at -$4.46, and the highest EPS forecast at -$2.13. In 2027, NRIX's EPS is forecast to hit -$3.23 (min: -$4.15, max: -$2.46).

What is NRIX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: NRIX) forecast ROE is -57.56%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.